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Human pluripotent stem cells (hPSCs) have gained a solid foothold in basic research and drug industry as
they can be used in vitro to study human development and have potential to offer limitless supply of
various somatic cell types needed in drug development. Although the hepatic differentiation of hPSCs
has been extensively studied, only a little attention has been paid to the role of the extracellular matrix.
In this study we used laminin-511, laminin-521, and ﬁbronectin, found in human liver progenitor cells, as
culture matrices for hPSC-derived deﬁnitive endoderm cells. We observed that laminin-511 and laminin-
521 either alone or in combination support the hepatic speciﬁcation and that ﬁbronectin is not a vital
matrix protein for the hPSC-derived deﬁnitive endoderm cells. The expression of the laminin-511/521-
speciﬁc integrins increased during the deﬁnitive endoderm induction and hepatic speciﬁcation. The
hepatic cells differentiated on laminin matrices showed the upregulation of liver-speciﬁc markers both at
mRNA and protein levels, secreted human albumin, stored glycogen, and exhibited cytochrome P450
enzyme activity and inducibility. Altogether, we found that laminin-511 and laminin-521 can be used as
stage-speciﬁc matrices to guide the hepatic speciﬁcation of hPSC-derived deﬁnitive endoderm cells.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
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r Ltd. This is an open access article(ECM). The ECM provides essential cues for cell proliferation,
migration, and differentiation [1]. The secretion of the ECM starts
already at the embryonic stage, and its remodeling is an important
mechanism by which tissue formation is regulated [2,3]. Indeed,
the topology and composition of the ECM are not static during
embryonic development or in tissue homeostasis and regeneration.
Moreover, the ECM chemistry varies between the zones in the liver
[4]. However, the role of the ECM in speciﬁc lineage stages is largely
undiscovered. Human pluripotent stem cells (hPSCs) offer a useful
in vitro tool to study the cell-ECM interactions during human
development as the in vivo research on human development is
typically hindered by ethical concerns. In addition, studying spe-
ciﬁc ECM proteins can lead to the development of new bioinspired
matrices for in vitro hepatic differentiation.
In vitro hepatic differentiation of both human embryonic stem
cells (hESCs) and human induced pluripotent stem cells (hiPSCs)
has been tremendously studied [5e10]. The hepatic differentiation
is most often guided through deﬁnite endoderm (DE) and hepatic
progenitor to obtain hepatocyte-like cells [11] as this step-wiseunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
L.K. Kanninen et al. / Biomaterials 103 (2016) 86e100 87procedure follows the natural differentiation process [12]. In the
majority of differentiation protocols cell-matrix interactions have
been neglected; differentiation process is guided solely by soluble
factors, and hPSC derivatives are cultured on the same matrix used
initially for plating stem cells. For creating a robust and scalable
stem cell differentiation protocol cell culture matrix should desir-
ably be well-deﬁned and xeno-free. However, the optimal culture
matrix for in vitro hepatic differentiation of the DE cells is poorly
understood. A purpose-driven development of new culture
matrices should begin by learning from the composition and dis-
tribution of the ECM proteins in the tissue of interest. It has earlier
been suggested that new biomaterials for liver cell cultures can be
found by characterizing ECM proteins in a liver acellular matrix
(ACM) [13]. We recently proposed a simpler approach to ﬁnd
lineage stage-speciﬁc matrices by using cell lines [14]. We created
an ACM from human liver progenitor HepaRG cells to mimic the
matrix of liver progenitors and used the ACM for differentiating
hPSC-derived DE cells according to our hypothesis that liver
progenitor-like matrix could induce efﬁcient hepatic lineage spec-
iﬁcation of DE cells. Indeed, we were able to show that liver
progenitor-like matrix supported the differentiation of DE cells
towards hepatocytes.
To produce a chemically deﬁned matrix that mimics the
HepaRG-ACM, in this study, we characterized the matrix compo-
nents produced by HepaRG cells and found that laminin-511 (LN-
511), laminin-521 (LN-521), and ﬁbronectin were highly expressed.
Furthermore, we showed that LN-511 and LN-521 can be used as
culture matrices for hepatic speciﬁcation and differentiation of
hPSC-derived DE cells.
2. Materials and methods
2.1. Characterization of the ECM proteins in liver progenitor cells
HepaRG cells [15] obtained from Biopredict (Saint-Gregoire,
France) were cultured for two weeks in earlier described culture
conditions. The ECM mRNA and protein expression of the HepaRG
cells was characterized by conventional RT-PCR and immunoﬂuo-
rescence, respectively (see sections 2.4e2.6 below).
2.2. Cell cultures
The hESC lines WA07 and H9 [16] and hiPSC line iPS(IMR90)-4
[17] were bought from WiCell research institute. H9 cells were
genetically modiﬁed to H9-GFP cells as earlier reported by us [18].
All the stem cell lines were maintained in Matrigel culture system
(BD Biosciences, 356230, 0.5 mg per one 6-well plate) in mTeSR™1
medium (STEMCELL™ Technologies, 05850) which was renewed
daily. The WA07 and iPS(IMR90)-4 cells were passaged at ratios of
1:4e1:8 by using Versene 1:5000 (Invitrogen, 15040033) and the
H9-GFP cells were passaged at ratios of 1:4e1:6 by using Dispase
(STEMCELL™ Technologies, 07923). The WA07, H9-GFP, and
iPS(IMR90)-4 cells used in this study were at passages p40,
p25(20)-p26(21), and p18 þ 40(15)-p18 þ 42(17), respectively.
HepaRG cells were used as control cells in real-time qPCR. The
HepaRG cells were cultured for two or four weeks in the conditions
described previously [15,19]. In the four-week culture, the medium
was supplemented with 2% DMSO during the last two weeks to
induce the hepatic maturation. All the cell cultures were main-
tained at 37 C in a humid atmosphere with 5% CO2.
2.3. Differentiation of hPSCs to DE and hepatic cells
The iPS(IMR90)-4, WA07, and H9-GFP cells were induced to DE
cells during six days as reported earlier [14]. RPMI-1640 medium(Gibco, 31870-025) with earlier described supplements [20,21] 1 
B-27 (Gibco, 17504-044), 100 ng/ml Activin A (PeproTech, 120-14E),
75 ng/ml Wnt-3a (R&D Systems, 5036-WN), and 1 mM (day 0) -
0.5 mM (days 1e5) sodium butyrate (Sigma Aldrich, B5887) was
used for the H9-GFP cells. For the iPS(IMR90)-4 andWA07 cells the
media were supplemented with 1  B-27 and 100 ng/ml Activin A.
For hepatic speciﬁcation we plated the DE cells on seven
different matrices with all possible combinations of LN-521, LN-511,
and ﬁbronectin (M1-M7; Fig. 2B). Human rLN-511 and human rLN-
521 (Biolamina; LN511-01 and LN521-01, respectively) were used at
a concentration of 20 mg/ml and ﬁbronectin (Sigma-Aldrich, F0895)
at a concentration of 25 mg/ml. All the coating solutions were
prepared in 1  DPBS with calcium and magnesium and incubated
in culture wells either for two hours at 37 C (fast coating) or for
overnight at 4 C (slow coating). After the use, coating solutions
were collected, stored at 20 C, and reused up to two times.
Standard tissue culture treated dish was used as a control. The DE
cells were gently detached by an enzyme-free Cell Dissociation
Buffer (Gibco, 13151-014) for 15 min at 37 C followed by an
Accutase cell detachment solution (Millipore, SCR005) for one to
two minutes at room temperature. The H9-GFP-derived DE cells
were detached from 6-well plates and seeded at a ratio of 1:1 onto
the matrices. To ﬁnd the optimal seeding protocol for each cell line,
the WA07 and iPS(IMR90)-4-derived DE cells were ﬁrst seeded to
M1 at the following densities: 20 000 cells/cm2, 50 000 cells/cm2,
and 100 000 cells/cm2. Later the differentiation was performed
with the optimal density of 50 000 cells/cm2 for WA07 and
100 000 cells/cm2 for iPS(IMR90)-4 cells.
The DE cells on all the studied matrices were cultured in He-
patocyte Culture Medium (HCM™ SingleQuots™ Kit; Lonza CC-
4182, without rhEGF and gentamicin-amphotericin-1000) supple-
mented with 5 ng/ml ﬁbroblast growth factor 4 (FGF4, PeproTech,
100-31), 10 ng/ml bone morphogenetic protein 2 (BMP2, Pepro-
Tech, 120-02), and 10 ng/ml BMP4 (PeproTech, 120-05) for four
days. During the following four to six days the cells were incubated
in HCM supplemented with 10 ng/ml hepatocyte growth factor
(HGF, PeproTech, 100-39), 10 ng/ml Oncostatin M (OSM, PeproTech,
300-10T), and 0.1 mM Dexamethasone (DEX, Sigma-Aldrich,
D4902). In the last step of differentiation the cells were cultured
in HCM supplemented with 0.1 mM DEX and 10 ng/ml OSM or only
with DEX for four to six days.
2.4. Immunoﬂuorescence staining
For immunoﬂuorescence staining cells were cultured in either
8-well Lab-Tek® Chamber Slide™ systems (Nunc, 177445) or black
96-well m-plates (ibidi, 89626). The cells were ﬁxed with 4% para-
formaldehyde for 10 min, permeabilized with either 0.1% Triton X-
100 or 0.5% Saponin for 10 min except for CXCR-4 staining, and
blocked with 10% normal goat or donkey serum (Millipore) for one
hour. The cells were then incubated overnight at 4 C with the
primary antibodies listed in Table S1. Negative controls include
non-immunized goat, mouse, or rabbit IgG used at the same con-
centrations as the corresponding primary antibodies. On the
following day the cells were incubatedwith the secondary antibody
conjugated with Alexa Fluor 594 (Invitrogen, 1:400) for one hour.
Cell nuclei were stained with DAPI (Sigma-Aldrich, D8417, 25 mg/ml
in MilliQ water) for two minutes or with 0.2 mM SYTOX green
(Invitrogen, S7020) for 30 min. Samples in Chamber Slides were
mounted with a ProLong® Gold antifade reagent (Invitrogen,
P36934). The protein expressionwas visualized on a Leica TCS SP5II
HCS A confocal microscope with an HCX PL APO 20/0.7 Imm Cor
(glycerol) objective or HC PL APO 0.7 CS air objective. DAPI was
excited with UV (diode 405 nm/50 mW), SYTOX green with an
Argon 488 nm laser, and Alexa Fluor 594 with a DPSS (561 nm/
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Immunostaining of negative controls was used to setup confocal
parameters, and they showed no positive staining (data not
shown). The images were analyzed with Imaris 8.1.2 program
(Bitplane) by creating slices or easy three-dimensional images.
Immunoﬂuorescence of the H9-GFP-derived DE cells was imaged
with a Zeiss Axioplan microscope.
2.5. RNA isolation and cDNA conversion
Total RNA was extracted from HepaRG, H9-GFP cells, and their
derivatives using a TRIzol reagent (Invitrogen, 15596) following the
manufacturer's instructions. All the other cells were lysed with a
RLT-buffer (Qiagen), and total RNA was extracted using an RNeasy
Mini kit (Qiagen, 74104) according to the manufacturer's in-
structions. Primary human hepatocytes (PHHs; BD Biosciences,
454503, lot 99 and 95) were used as controls. Cryopreserved he-
patocytes (lot 99) were from a 29 year old female donor and lot 95
from a 13 year old male donor. The frozen PHHs were recovered by
using a cryopreserved hepatocyte puriﬁcation kit (BD Biosciences,
454500) according to themanufacturer's instructions. The RNAwas
converted to cDNAwith a High Capacity RNA-to-cDNA kit (Applied
Biosystems, 4387406). The cDNA samples were used in conven-
tional PCR and qPCR.
2.6. Conventional RT-PCR
The gene expression of the ECM proteins in HepaRG cells was
measured by conventional PCR using a KAPA HiFi HotStart kit
(KAPA Biosystems, KK2501). Each PCR reaction consisted of 0.5 U
KAPA HiFi HotStart DNA polymerase, 20 ng cDNA, 0.3 mM primers,
0.3 mM dNTP mix, 1  KAPA HiFi buffer, and PCR grade water. The
primer sequences are listed in Table S2. The PCR cycles were per-
formed on a DNA Engine Dyad Peltier Thermal Cycler (Bio-Rad
Laboratories). The PCR cycling conditions were: initial denaturation
at 95 C for 5 min followed by 25 cycles of 20 s denaturation at
98 C, 15 s annealing at 60 C, and 30 s extension at 72 C. The PCR
cycles were followed by a ﬁnal extension at 72 C for 5 min and
cooling at 4 C. The PCR products were examined by standard
agarose gel electrophoresis (1% agarose, 0.5 mg/ml ethidium bro-
mide,1 TBE at pH 8.0) and visualized under a UV transilluminator
with a CCD camera with a motor-operated zoom lens (Syngene
Gene Genius Bio Imaging System, Synoptics). The size of the PCR
products was assessed by comparison with an O'GeneRuler™ Low
Range DNA Ladder (Fermentas, SM1203).
2.7. qPCR
The cDNA samples were analyzed on a StepOnePlus Real-Time
PCR System (Applied Biosystems) using a Fast SYBR Green Master
Mix (Applied Biosystems, 4385612) or TaqMan Universal Master
Mix II (Applied Biosystems, 4440038). Housekeeping gene ribo-
somal protein, large, P0 (RPLP0) served as an endogenous control.
All used primers and TaqMan Gene Expression Assay mixes are
listed in Tables S2 and S3, respectively. The primers were designed
by Primer Express v2.0 software (Applied Biosystems) except the
primers for OCT4 [17] and HNF3B [20], and were synthesized by
Oligomer Oy (Helsinki, Finland). A standard curve for each genewas
generated, and ampliﬁcation efﬁciency was taken into account in
calculation of the relative quantiﬁcation of each target gene in
comparison with the housekeeping gene with an earlier described
mathematical model [22]. The relative gene expression was calcu-
lated with reference to the undifferentiated hPSCs on day 0, which
represents one.2.8. Albumin (ALB) secretion
Hepatic functionality was assessed by measuring human ALB
secretion over time. Conditioned media samples of iPS(IMR90)-4
and H9-GFP cells were analyzed with a Human Albumin ELISA
Quantiation Set (Bethyl Laboratories, E80-129) according to the
manufacturer's protocol. To normalize secreted ALB amount, total
cellular protein content was analyzed. Cells were lysed with 1 
RIPA buffer (ThermoFisher Scientiﬁc, 89901) supplemented with 1
 protease inhibitor cocktail (Sigma Aldrich, P8340) after which the
protein amount was measured with a Pierce BCA Protein Assay Kit
(ThermoFisher Scientiﬁc, 23227) by following the manufacturer's
instruction.2.9. Cytochrome P450 (CYP) enzyme activity and induction
The activity of CYP3A enzymes was followed over time in the
hPSC-derived cells with a P450-Glo™ CYP3A Assay with Luciferin-
PFBE (Promega, V84901). The cell monolayer was washed twice
with basal media before adding 50 mM CYP3A substrate diluted in
the basal media. After eight-hour incubation luminescence was
generated by adding Luciferin Detection Reagent and the formed
light was recorded with a plate reader (Varioskan Flash, Thermo
Fisher Scientiﬁc) [23]. The cells were then lysed with 1  RIPA
buffer as described above to normalize the luminescence to total
protein amount. The induction of CYP3A4, CYP3A7, CYP1A1, CYP1A2,
and CYP1B1 expression were examined with known inducers. The
cells were exposed to 50 mM DEX (in 0.1% DMSO) for 48 h to
induce CYP3A4 and CYP3A7 or to 100 mM omeprazole (OMZ; in 0.1%
DMSO) to induce CYP1A1, CYP1A2, and CYP1B1. Control cells were
treated with 0.1% DMSO for 48 h. RNA lysates, RNA isolation, cDNA
conversion, and real-time qPCR were performed as described
above.2.10. Periodic Acid Schiff (PSA) staining for glycogen
Glycogen production was analyzed by PAS staining. The hPSC-
derived cells and HepaRG cells were ﬁxed with 4% para-
formaldehyde for 10 min at room temperature. Human liver tissue
was obtained from harvested organs for liver transplantation in the
Transplantation and Liver Surgery Clinic (Helsinki, Finland). Human
liver tissue sample was ﬁxed with 4% paraformaldehyde overnight
at 4 C. Subsequently, the standard parafﬁn embedding and
sectioning were performed at the Finnish Center for Laboratory
Animal Pathology. 5 mm-thick sections were used in PSA staining.
The cells and deparafﬁnized tissue sections were treated with 0.5%
periodic acid solution for 5 min. After washing with distilled water
the cells were incubated with Schiff's reagent for 15 min, and the
reagent was thenwashed away extensively with running tap water.
The stained samples were imaged with a phase contrast micro-
scope (Leica DM IL LED) with LAS EZ software (Leica Microsystems).
The use of human liver tissue was authorized by the National Su-
pervisory Authority for Welfare and Health and by the Hospital
District of Helsinki and Uusimaa Ethics Committee Department of
Surgery.2.11. Statistical analysis
Statistical signiﬁcance was determined by Student's t-test
(Fig. 7E) or by one-way analysis of variance (ANOVA) followed by
Holm-Sidak post-test (Sigma Plot 11.0; Figs. 5C, 7D, and 8). Differ-
ences of P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) were
considered signiﬁcant.
L.K. Kanninen et al. / Biomaterials 103 (2016) 86e100 893. Results
3.1. Characterization of the ECM proteins in HepaRG cells
We have earlier shown that the human liver progenitor
HepaRG-ACM supports the attachment and hepatic differentiation
of hPSC-derived DE cells [14]. To produce a chemically deﬁned
matrix that mimics the HepaRG-ACM, we characterized the ECM
proteins in HepaRG cells by conventional RT-PCR and immunoﬂu-
orescence. Fig.1A summarizes themRNA and proteins expressed by
the HepaRG cells. Fibronectin, laminin a2, a5, b1, b2 and g1 chains,
and collagen type IV a1, a2 and a5 chains were detected at mRNA
level (Fig. S1). Fibronectin, laminin a5 chain, and collagen type IV
a2 and a5 chains were also detected at protein level as shown by
immunoﬂuorescence (Fig. 1B). Collagen type IV a2 and a5 chains
cannot assemble any known heterotrimers as only three hetero-
trimers, namely a1a1a2, a3a4a5, and a5a5a6, have been discov-
ered [24]. This result suggests that HepaRG cells produce
ﬁbronectin, LN-511 (composed of a5, b1, and g1 chains), and LN-
521 (composed of a5, b2, and g1 chains) proteins.3.2. Characterization of hPSCs and their differentiation to DE cells
Prior to DE and hepatic differentiation, the hPSC cells were
characterized in terms of their pluripotency. The WA07 and
iPS(IMR90)-4 cells expressed the key pluripotent markers OCT4
and SSEA-4, and H9-GFP expressed OCT4 as shown by immuno-
ﬂuorescence (Fig. S2A). The stem cells were negative for hepatic
markers AFP, ALB, and HNF4A (data not shown). In the next step of
differentiation, the cells were induced to DE cells according to
earlier published protocols [14,21]. The DE cells derived from all
three different hPSC lines highly expressed HNF3B and CXCR-4
(Fig. S2B) but were negative for AFP (data not shown).Fig. 1. Characterization of the ECM components produced by the human liver progenitor H
conventional RT-PCR and immunoﬂuorescence (IF). B) Immunoﬂuorescence of ﬁbronectin
bars ¼ 100 mm. Controls in which the primary antibody was replaced with the corresponding
staining (data not shown).3.3. Studying ECM components for hepatic differentiation
Here we tested the ECM proteins ﬁbronectin, LN-511, and LN-
521 that are found in HepaRG cells, and all their possible combi-
nations for the attachment of DE cells to create a xeno-free, human
liver progenitor-speciﬁc culture matrix. After six days of DE in-
duction the cells were detached and transferred to the studied
matrices. The DE cells were differentiated towards hepatic cells
with a three-step treatment: hepatic speciﬁcation, hepatic pro-
genitor expansion, and hepatic maturation (Fig. 2A).
To identify if one of the ECM proteins found in HepaRG cells had
an essential role in hepatic speciﬁcation, we ﬁrst plated the H9-
GFP-derived DE cells onto four matrices with the combinations of
two to three proteins, namelyM1 (LN-511, LN-521, and ﬁbronectin),
M2 (LN-511 and LN-521), M3 (LN-511 and ﬁbronectin), andM5 (LN-
521 and ﬁbronectin). If the differentiation potency was decreased
on one of the two-protein conditions compared with the three-
protein condition, the excluded protein would be an essential
matrix in hepatic speciﬁcation. To know the concentration of LN511
and LN-521, we tested 10 mg/ml that is recommended by the sup-
plier and 20 mg/ml. One day after seeding the H9-GFP-derived DE
cells to the four matrices, we noticed that the attached cells were
much more on the matrices with 20 mg/ml LN-511 or LN-521
(Fig. S3). Therefore, in the subsequent studies, we used LN-511
and LN-521 at 20 mg/ml. On day 10, the H9-GFP-derived progeni-
tor cells expressed HNF4A and AFP at protein level in all four
studied culture conditions as observed by immunoﬂuorescence
(Fig. S4A). On day 21, the hepatic cells differentiated from the H9-
GFP cells highly expressed ALB, and many cells lost the expres-
sion of AFP (Fig. S4B).We did not observe any signiﬁcant differences
in the expression of the hepatic markers between the matrices M1,
M2, M3, and M5. The ﬁnding was conﬁrmed with the studies of
gene expression and ALB secretion. The mRNA expression of each
hepatic marker (ALB, AAT, CK-19, CK-8, CK-18, and AFP) in the H9-
GFP-derivatives on day 21 was at the similar level in all fourepaRG cells. A) The summary of the ECM components analyzed in the HepaRG cells by
, laminin a5, collagen type IV a2, and collagen type IV a5 in the HepaRG cells. Scale
non-immunized goat, mouse, or rabbit IgG at the same concentration show no positive
Fig. 2. Hepatic differentiation of the hESC and hiPSC-derived DE cells in ﬁbronectin, laminin-511, and laminin-521-based culture systems. A) Differentiation protocol. *Wnt-3a and
sodium butyrate (NaBut) were used for the H9-GFP-derived DE cells. **Oncostatin M (OSM) supplement was tested with the iPS(IMR90)-4 and WA07 derivatives to improve hepatic
maturation but was removed from the media as it caused cytoplasmic vacuoles extensively. B) The components used in the tested matrices M1, M2, M3, M4, M5, M6, and M7.
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As we were not able to identify if one of the proteins of interest
had more crucial role than the others in the hepatic differentiation
by screening them in combinations of two or three, we plated the
hPSC-derived DE cells on matrices composing of only one protein.
In addition to single protein matrices, M4 (LN-511), M6 (LN-521),
and M7 (ﬁbronectin), we repeated the cell differentiation on
matrices M1, M2, M3, and M5 with iPS(IMR90)-4 and WA07 cell
lines. Before an extensive study of seven matrices, we optimized
the seeding density for the DE cells derived from iPS(IMR90)-4 and
WA07 cells using M1. For the iPS(IMR90)-4 cells the optimal DE
seeding density was 100 000 cells/cm2 since the other tested
densities, 20 000 cells/cm2 and 50 000 cells/cm2, did not yield as
high expression level of AFP and HNF4A on day 10 (Fig. S5A). In
addition, the AFP expression in the cells seeded at the density of
100 000 cells/cm2 was the lowest on day 21 (Fig. S5C). For the
WA07-derived DE cells the seeding densities 50 000 cells/cm2 and
100 000 cells/cm2 resulted in very similar AFP and HNF4A
expression patterns on day 10 (Fig. S5B), and on day 21 no
remarkable differences were observed between the studied den-
sities (Fig. S5D). Based on these results, the experiments were
continued with the density of 100 000 cells/cm2 for the
iPS(IMR90)-4 cells and with the density of 50 000 cells/cm2 for the
WA07 cells.
The hepatic speciﬁcation of the iPS(IMR90)-4 and WA07-
derived DE cells was efﬁcient on most of the studied matrices. On
day 10, most of the iPS(IMR90)-4 derivatives expressed HNF4A on
all the matrices except on M7 as shown by immunoﬂuorescence
(Fig. 3A). The WA07-derived cells cultured on the matrices M1eM7
expressed HNF4A (Fig. 3B). On day 21, the hepatic cells derived
from the iPS(IMR90)-4 and WA07 cells were partially positive for
ALB (Fig. 4). The lowest ALB expressionwas seen in the iPS(IMR90)-
4 derivatives on M2 (Fig. 4A) and in WA07 derivatives on M1 and
M7 (Fig. 4B). Otherwise there was no clear difference between the
studied matrices. As we did not observe any signiﬁcant improve-
ment in the hepatic speciﬁcation or maturation with the presence
of ﬁbronectin, we continued the future studies with the matricescontaining only laminins: M2, M4, and M6.
We plated the hPSC-derived DE cells after six days of differen-
tiation to plastic and did not observe cell attachment (Fig. S6A). In
contrast, the DE cells plated on the matrices M2, M4, and M6
attached well and formed more than 80% conﬂuent monolayer one
day after seeding (Fig. 5A and B). We did not see any difference in
the DE cell attachment on day 1 when preparing the laminin
coatings with the fast protocol (2 h at 37 C) or with slow coating
(overnight at 4 C; Fig. S6B). In addition, we observed that the
lamininworking solutions can be reused at least two times without
causing any difference in the cell attachment (Fig. S6C).
3.4. Characterization of hPSC-derived hepatic cells
After screening the optimal DE seeding density and ECM pro-
teins we continued the study with iPS(IMR90)-4 cell line and
partially with WA07 cell line using the matrices M2, M4, and M6.
We followed the differentiation by examining cell morphology,
hepatic marker expression at mRNA and protein levels, and hepatic
functions.
The cells exhibited typical morphologies during SC, DE, and
hepatic differentiation steps (Fig. 5A and B). The cell size greatly
increased during the differentiation from day 10 to day 16 (Fig. 5A
and B), which is a phenomenon occurring during the maturation of
hepatocytes in vivo [25]. Already on day 16, the derived cells
exhibited polygonal-shaped morphology, and some cells were
binucleated. The morphology of the derived hepatic cells resem-
bled earlier described hESC-derived hepatocytes [10,26] and PHHs
in culture [27e29].
To understand the cell-matrix interactions, we studied the
expression of integrin subunits ITGA3, ITGA6, ITGA7 (including two
splice variants ITGA7X1 and ITGA7X2), ITGB1, and ITGB4 in the
iPS(IMR90)-4 cells, DE cells (day 6), and derived cells on day 10
corresponding to four-day culture on the studied matrices M2, M4,
and M6. These integrin subunits can form the major laminin-
binding integrins a3b1, a6b1, a7X1b1, a7X2b1, and a6b4. In gen-
eral, the integrin expression proﬁles changed drastically between
Fig. 3. Hepatic speciﬁcation of the hPSC-derived DE cells on the seven matrices. Immunoﬂuorescence of HNF4A in A) the iPS(IMR90)-4-derived progenitor cells and B) WA07-
derived progenitor cells on day 10. Scale bars ¼ 100 mm. Controls in which the primary antibody was replaced with the corresponding non-immunized goat IgG at the same
concentration show no positive staining (data not shown).
L.K. Kanninen et al. / Biomaterials 103 (2016) 86e100 91the analyzed time points (Fig. 5C). The expression of integrin a
subunit ITGA3 signiﬁcantly increased on day 10 compared with the
hPSCs and DE cells. In turn, its expression in the PHHs was lower
than that in the hPSCs. A similar expression pattern was observed
with a subunit ITGA7X1 and b subunit ITGB4whose expression was
the highest in the derived cells on day 10. Comparedwith the hPSCs
the expression of ITGA6 and ITGA7X2 mRNA in the DE cells and
derived cells on day 10was signiﬁcantly lower, whichwas similar to
the level in the PHHs. The expression of ITGB1 signiﬁcantly
increased in the derived cells on day 10, which was similar to the
level in the PHHs. The expression of the studied integrins were at
the same levels between the cells cultured on M2, M4, and M6
except for ITGB1 whose expression was signiﬁcantly higher on M6compared with M4 (P < 0.05).
The iPS(IMR90)-4-derived progenitors on M2, M4, and M6
expressed CK-19 and AFP on day 10 (Fig. 6A). The AFP expression on
M6 was weak. At the last studied time point, on day 21, the
iPS(IMR90)-4 derivatives were partially positive for AFP. Although
CK-19 was still expressed, it did not exhibit clear ﬁlaments as seen
on day 10 (Fig. 6B). The hepatocyte-speciﬁc marker CK-18 was
expressed in all the studied matrices on day 21. The expression of
the hepatic markers HNF4A and ALB in the iPS(IMR90)-4-derived
cells is described in section 3.3 (Figs. 3 and 4).
Both the iPS(IMR90)-4-derived and H9-GFP-derived cells
secreted human ALB conﬁrming their hepatic functions (Fig. 7A). In
the H9-GFP-derived cells the ALB secretion drastically increased
Fig. 4. Hepatic differentiation of the hPSC-derived DE cells on the seven matrices. Immunoﬂuorescence of ALB in hepatocyte-like cells derived from A) the iPS(IMR90)-4 cells and B)
WA07 cells on day 21. Scale bars ¼ 100 mm. Controls in which the primary antibody was replaced with the corresponding non-immunized goat IgG at the same concentration show
no positive staining (data not shown).
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iPS(IMR90)-4-derived cells the ALB secretion could not be detected
on day 10 yet, but it increased at the next studied time points, days
16 and 20.
Glucose metabolism was characterized by staining the stored
glycogen with PAS. Similarly to hepatocytes in the human liver, the
iPS(IMR90)-4-derived cells showed positive PAS staining (Fig. 7B).
The iPS(IMR90)-4-derived hepatic cells cultured on M6 were more
positive for PAS on day 21 compared with HepaRG cells.
The hepatocyte phenotype of the derived cells was also studied
in terms of their detoxiﬁcation functions. CYP3A4 protein was
strongly expressed in the iPS(IMR90)-4-derived cells on day 21
cultured on M4 and M6, but its expression was remarkably loweron M2 (Fig. 7C). CYP3A enzyme activity signiﬁcantly increased
during the differentiation period, and on the last studied time point
the activity was signiﬁcantly higher than that in HepaRG cells
(Fig. 7D). Inducibility of CYP enzymes were studied with known
inducers, omeprazole (OMZ; for CYP1A1, CYP1A2, and CYP1B1) and
dexamethasone (DEX; for CYP3A4 and CYP3A7). The treatment
with OMZ induced the mRNA expression of CYP1A1 and CYP1B1 in
the iPS(IMR90)-4-derived cells cultured on M6 by approximately
1000 times and 12 times compared with DMSO-treated control
cells, respectively (Fig. 7E). The CYP1A1 induction fold change was
only one third in HepaRG cells compared with the iPS(IMR90)-4-
derived hepatic cells (Fig. 7E). The expression of CYP1B1 mRNA
was induced at the similar levels both in the iPS(IMR90)-4-derived
Fig. 5. Phase contrast microscope images of the hPSCs, DE cells, and their hepatic derivatives on M2, M4, and M6 at different time points. A) The iPS(IMR90)-4 cells. B) The
WA07 cells. Scale bars ¼ 100 mm. C) Expression proﬁle of integrin subunits analyzed by real-time qPCR in the iPS(IMR90)-4 cells (SC), DE cells on day 6, and derived cells on day 10
corresponding to four-day culture on the studied matrices M2, M4, and M6. The relative mRNA expression of integrin subunits ITGA3, ITGA6, ITGB1, ITGB4, ITGA7X1, and ITGA7X2was
normalized to the control gene RPLP0, and fold inductions were calculated with reference to the undifferentiated stem cells on day 0 (SC). N ¼ 3 biological samples. Error bars
represent SD. The differences between the iPS(IMR90)-4 cells and their derivatives were analyzed by one-way ANOVA followed by Holm-Sidak post-test. The statistically signiﬁcant
differences are shown as *P < 0.05, **P < 0.01, and ***P < 0.001. PHH(M): primary human hepatocytes (BD Biosciences, 454503, lot 95); PHH(F): primary human hepatocytes (BD
Biosciences, 454503, lot 99). ND ¼ not detectable.
Fig. 6. Immunoﬂuorescence staining of CK-19, AFP, and CK-18 in the iPS(IMR90)-4-derived cells cultured on M2, M4, and M6. A) The hepatic progenitor cells on day 10. B) The
hepatocyte-like cells on day 21. Scale bars ¼ 100 mm. Controls in which the primary antibody was replaced with the corresponding non-immunized mouse IgG at the same
concentration show no positive staining (data not shown).
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Fig. 7. Hepatic synthetic functions, energy metabolism, and detoxiﬁcation function in the hPSCs-derived cells. A) ALB secretion in the iPS(IMR90)-4-derived cells (a1) and in the H9-
GFP-derived cells (a2) cultured on M2. For iPS(IMR90)-4 derivatives N ¼ 3 biological samples and for H9-GFP derivatives N ¼ 2 biological samples. Error bars represent SD (a1) and
the minimal and maximal values (a2). B) Glycogen production in the iPS(IMR90)-4-derived hepatic cells on day 21 cultured on M6 (b1), in a human liver (b2), and in the HepaRG
cells (b3) as shown by PAS staining. Scale bars ¼ 100 mm. C) Immunoﬂuorescence of CYP3A4 enzyme in the iPS(IMR90)-4-derived cells on day 21 cultured on M2 (c1), M4 (c2), and
M6 (c3). Scale bars ¼ 100 mm. Controls in which the primary antibody was replaced with the corresponding non-immunized rabbit IgG at the same concentration show no positive
staining (data not shown). D) Metabolic activity of CYP3A enzymes in the iPS(IMR90)-4 cells and their derivatives during the hepatic differentiation. The differences between all
pairs were analyzed by one-way ANOVA followed by Holm-Sidak post-test. The statistically signiﬁcant differences between the iPS(IMR90)-4 cells (SC) and their derivatives are
shown above bars as ***P < 0.001. The statistically signiﬁcant difference between the cells on day 21 and HepaRG cells is shown above lines as ***P < 0.001. For stem cells N ¼ 3
biological samples, and for the iPS(IMR90)-4-derivatives and HepaRG cells N ¼ 4 biological samples. Error bars are SD. E) Induction of CYP enzymes with omeprazole (OMZ) and
dexamethasone (DEX) in the iPS(IMR90)-4-derived cells on day 21 cultured on M6 (e1) and in HepaRG cells (e2). N ¼ 4 biological samples. Error bars are SD. The line represents
DMSO-treated control cells ¼ 1. The difference between the DMSO-treated control cells and inducer-treated cells was analyzed by Student's t-test. The statistically signiﬁcant
differences are shown as ***P < 0.001.
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expressed in the derived cells after the induction but not detectable
in the control cells (data not shown). Exposure to DEX upregulated
themRNA expression of CYP3A7 and CYP3A4 in the cells cultured on
M6 by 1.7 and 1.6 times compared with the control cells, respec-
tively (Fig. 7E). However, the induction fold was not statistically
signiﬁcant.
3.5. Gene expression proﬁles of hPSCs and their hepatic derivatives
We performed comprehensive gene expression proﬁling with
iPS(IMR90)-4 cell line by assessing the markers for pluripotent
cells, DE cells, hepatic progenitors, fetal hepatocytes, and mature
hepatocytes by qPCR (Fig. 8). The mRNA expression of the
iPS(IMR90)-4 derivatives cultured on M2, M4, and M6 was
compared with stem cells to show the relative expression. The
PHHs and HepaRG cells were used as controls. The mRNA expres-
sion of the key pluripotent marker OCT4 in the iPS(IMR90)-4 de-
rivatives after 14 days in culture in all the studied culture matrices
was at the similar level as in the PHHs. The NANOG expression
signiﬁcantly decreased from the stem cell stage already on day 10.
ThemRNA expression ofHNF3B (also known as FOXA2) was 240-
fold upregulated in the DE cells on day 6 after which the gene
expressionwas signiﬁcantly downregulated by 100 times already in
the hepatic progenitors on day 10. At the last studied time point, on
day 21, the HNF3B expression was nearly at the same level as in
stem cells, and remarkably lower than the levels in the PHHs and
HepaRG cells. The gene expression of the liver progenitor marker
AFP increased from the stem cell level approximately 80e120 times
on day 10, and reached the maximal expression on day 14. On day21, the AFP expression was downregulated but the level of its
expression in all the studied matrices was higher than that in the
PHHs. CK-19 is a marker for hepatic progenitors and cholangiocytes
[11], and it is also present in fetal hepatocytes [30]. In the
iPS(IMR90)-4-derived hepatic progenitors the CK-19 expression
increased circa 25 times from the stem cell stage and remained
nearly constant on day 14. On day 18, the expression was down-
regulated approximately 10 folds to the level which was main-
tained until the end of the culture. The expression of the liver
speciﬁc cytokeratins CK-8 and CK-18was the highest on day 14 in all
three culture conditions, and later downregulated on day 18. On the
last studied time point, the expression levels of CK-8 and CK-18
were approximately 6 times and 5 times higher than those in the
control PHHs, respectively.
The expression of CYP3A7, expressed in fetal hepatocytes [31]
but only weakly in adult hepatocytes in vivo [11], was upregu-
lated in the iPS(IRM90)-4-derived cells on all the matrices M2, M4,
andM6. On day 21, the CYP3A7 expressionwas at the similar level to
the PHHs from a 13 year old male donor, lower than in the PHHs
from a 29 year old female donor, and higher than in HepaRG cells.
We observed also the upregulation of CYP3A4 expression, an
enzyme present only in mature hepatocytes [11], but the level of its
expression was signiﬁcantly lower compared to those in the PHHs
and HepaRG cells. The mRNA expression of CYP2C9 reached the
highest level on day 14 after which the expression level was stable.
CYP2B6 was not expressed in the iPS(IMR90)-4-derived cells at any
stage (data not shown). We determined the expression of nuclear
receptors NR3C1 (also known as glucocorticoid receptor, GR), NR1I2
(also known as pregnane X receptor, PXR), and aryl hydrocarbon
receptor (AhR). NR3C1 and NR1I2 mediate the induction of CYP3A
Fig. 8. Relative mRNA expression of pluripotency (OCT4 and NANOG), DE (HNF3B), and liver (CK-19, AFP, CK-18, CK-8, CYP3A7, CYP2C9, CYP3A4, AhR, NR3C1, ALB, and AAT) markers in
the iPS(IMR90)-4 cells during the differentiation analyzed by real-time qPCR. Relative mRNA expression was normalized to the control gene RPLP0, and fold inductions were
calculated with reference to the undifferentiated stem cells on day 0. For stem cells and DE cells, N ¼ 3 biological samples. For hepatic derivatives on days 10, 14, 18, and 21, N ¼ 4
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The mRNA expression of NR3C1 was upregulated during the dif-
ferentiation, and on day 21 the level was approximately two times
lower than the levels in the PHHs or DMSO-treated HepaRG cells.
The AhR expression increased over four folds during the culture.
The NR1I2 was not expressed in the iPS(IMR90)-4 cells (data not
shown).
The hepatic differentiation of the iPS(IMR90)-4 cells was further
conﬁrmed by the increased ALB and alpha-1 antitrypsin (AAT)
expression during the culture. On the last day of culture, both the
ALB and AAT mRNA levels were signiﬁcantly higher than in stem
cells, but lower than the expression in the PHHs and HepaRG cells.
4. Discussion
Cells start to secrete ECM proteins already at the embryonic
stage [2]. The ECM has an essential role in the regulation of cell
differentiation and cell functions and in the maintenance of tissue
homeostasis [38]. ECM remodeling is an important mechanism by
which tissues and organs are formed [1,3]. We hypothesized that
hepatic speciﬁcation of hPSC-derived DE cells would be efﬁcient in
hepatic progenitor-like environment. We earlier showed that
HepaRG-derived ACM was a promising matrix for hepatic differ-
entiation of hPSC-derived DE cells [14]. To create a xeno-free and
chemically deﬁned differentiation platform for DE cells, in this
study, we ﬁrst characterized the ECM components of HepaRG cells
and then used the discovered components in hepatic speciﬁcation
of hPSC-derived DE cells.
4.1. HepaRG cells produce ﬁbronectin, LN-511, and LN-521
In the liver, the ECM chemistry varies during the development
and exhibits gradient from periportal (zone 1) to pericentral (zone
3) zones [25]. In zone 1 the matrix is composed of laminins,
collagen types III and IV, hyaluronans, heparin sulfate pro-
teoglycans, and chondroitin sulfate proteoglycans [25,39,40]. In
zone 3 the matrix is dominated by collagen type I and ﬁbronectin.
At least eight intrahepatic maturational lineage stages have been
suggested along the three zones [40], and they carry out distinct
functions [41]. Human hepatic stem cells [42] are precursors to
hepatoblasts that give rise to hepatocytes and cholangiocytes. Both
hepatic stem cells and hepatoblasts are located in periportal zone 1
in the liver [43]. The liver ECM is dynamic. In vivo studies have
revealed a transient increase in laminins in regenerating liver and
that cells from regenerating liver attached better on laminins than
cells from normal liver [44].
We detected ﬁbronectin in the HepaRG cells by both conven-
tional RT-PCR and immunostaining. Fibronectin is a multidomain
protein that has a capacity to bind to cell surface receptors, colla-
gens, and other ﬁbronectin-binding molecules [45]. As ﬁbronectin
is found in most of human tissues [46], it has beenwidely used as a
coating material for culturing different cell types. Fibronectin has
earlier shown to promote self-renewal of hPSCs [47]. Mouse ESCs
cultured on ﬁbronectin coating were successfully differentiated to
DE-like cells [48]. When ﬁbronectin was used for plating hepatic
progenitors, it did not support their attachment and caused rapid
cell death [25]. Fibronectin supported the attachment of normal
mouse liver cells [44]. These ﬁndings indicate that ﬁbronectin, a
zone 3 matrix protein, can be used to culture mature hepatocytesbiological samples. ✝ N ¼ 3 biological samples. Error bars represent SD. The differences betw
statistically signiﬁcant differences between the iPS(IMR90)-4 cells (SC) and their derivative
ferences between the derivatives at two time points are shown above lines as *P < 0.05 or
PHH(F): primary human hepatocytes (BD Biosciences, 454503, lot 99); HepaRG 1: standard
weeks.but it may not be ideal for hepatic progenitors. In our study, we
observed that DE cells attached to ﬁbronectin and the cells could be
further differentiated to hepatocyte-like cells. However, as ﬁbro-
nectin is not a liver speciﬁc ECM protein andwe did not observe any
improvement in the cell differentiation efﬁcacy, we did not include
ﬁbronectin in our later studies.
We also found that HepaRG cells expressed collagen type IV a1,
a2, and a5 chains at mRNA level, but the expression of a1 chain
could not be conﬁrmed at protein level. Collagen type IV, composed
of three a-chains (a1ea6), is found only in the basement mem-
branes [24]. Collagen type IV found in the vascular basement
membranes and in the space of Disse in the liver is mostly
composed of a1 and a2 chains while the expression of the a3 and
a5 chains has been reported to be low [49]. So far, only collagen
type IV proteins a1a1a2, a3a4a5, and a5a5a6 have been discovered
in mammalian cells [24]. Since the identiﬁed collagen type IV a2
and a5 chains cannot assemble any known collagen type IV protein,
we did not use collagen type IV in our study.
Laminins, originally found in a mouse tumor in 1979 [50], are
ECM proteins present predominantly in the basement membrane
in most tissues in human [51,52]. These multidomain heterotrimers
are named on the basis of their a, b, and g chains [53]. Up to date,18
laminin isoforms have been described [51]. The laminin isoforms
have tissue speciﬁc locations, and they are vital for a number of
physiological functions. In this study, we found that HepaRG cells
produced both LN-511 and LN-521 conﬁrmed by immunostaining.
Our ﬁnding of the presence of laminin a5, b1, and b2 chains is in
agreement with an earlier ﬁnding in human liver [4]. Recombinant
human LN-511 (composed of a5, b1, and g1 chains; formerly known
as laminin-10) has earlier been used for culturing mouse PSCs [54]
and hPSCs [55], and human corneal endothelial progenitor cells
[56]. LN-521 (composed of a5, b2, and g1 chains; formerly laminin-
11) has been applied as a culture matrix for maintaining hPSCs [18]
and somatic cells [57], and for hiPSC reprogramming [58] and hiPSC
differentiation towards cell types such us cardiomyocytes [59] and
dopaminergic neurons [58].
Taken together, we have discovered that HepaRG cells secrete
abundantly zone 1 matrix proteins but only ﬁbronectin from the
class of zone 3 matrix proteins. It has previously been described
that the ECM components from zone 1 to zone 3 have dissimilar
effects on human liver progenitors in vitro [25].
4.2. LN-511 and LN-521 support efﬁcient hepatic speciﬁcation of DE
cells
Next, we used the identiﬁed matrix components in the hepatic
speciﬁcation of hPSC-derived DE cells. We found that LN-511 and
LN-521 supported efﬁcient hepatic speciﬁcation of hPSC-derived
DE cells. The H9-GFP, iPS(IMR90)-4, and WA07 cell lines differen-
tiated into HNF4A-expressing hepatic progenitor cells after four
days on LN-511 and LN-521. The other liver progenitor markers CK-
19 and AFP were also highly expressed in the derived cells on day
10. The iPS(IMR90)-4 andWA07-derived hepatocyte-like cells were
partially positive for ALB and CYP3A4 as observed by immunoﬂu-
orescence. The cells clearly changed their lineage state towards
maturation as the expression of AFP and CK-19 was signiﬁcantly
decreased from day 14 to day 21 shown by qPCR. All the derived
hepatic cells showed increased ALB secretion. We also character-
ized the energy metabolism functions in the derived cells byeen all pairs were analyzed by one-way ANOVA followed by Holm-Sidak post-test. The
s are shown above bars as **P < 0.01 or ***P < 0.001. The statistically signiﬁcant dif-
***P < 0.001. PHH(M): primary human hepatocytes (BD Biosciences, 454503, lot 95);
two-week culture; HepaRG 2: four-week culture with 2% DMSO during the last two
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derived hepatic cells indicates glycogen synthesis, which is one of
the key functions of hepatocytes.
Comparing with our earlier study using the HepaRG-ACM [14],
we have found that the use of recombinant matrix proteins is faster,
more consistent, more efﬁcient, and more scalable. In the ACM-
based system, the derived cells on day 10 were less positive for
HNF4A and negative for AFP, and the cells on the ﬁnal culture day
were much less positive for ALB and CYP3A4 [14]. The lower dif-
ferentiation efﬁciency in the ACM-based system could be due to the
loss of the matrix proteins during decellularization and variations
in matrix productions during two-week culture of the HepaRG
cells. The matrix concentrations in the ACM cannot be well deter-
mined, whereas the use of recombinant matrix proteins can be
easily standardized. We believe that the system presented in this
study is more advanced than our previously reported ACM-based
system.
Mouse and human ES cells have earlier been cultured on an ACM
prepared from human embryonic kidney cell line stably expressing
LN-511 followed by differentiation into hepatic lineages [60] and
pancreatic lineages [61]. A recent study showed hepatic differen-
tiation of hESCs on LN-521 [62]. Mouse hepatocytes cultured on a
LN-511/521-containing ACM maintained their liver-speciﬁc func-
tions longer than the cells cultured on Matrigel [63]. Best to our
knowledge, LN-511 and LN-521 have not been used earlier for the
differentiation of hPSC-derived DE cells.
Integrins are the main type of cell adhesion receptors that ani-
mal cells use to bind to the ECM [64]. They are heterodimeric
molecules composing of an a and a b subunit. We studied the
expression of the integrin subunits ITGA3, ITGA6, ITGA7 (including
two splice variants ITGA7X1 and ITGA7X2), ITGB1, and ITGB4, which
can form integrins a3b1, a6b1, a7X1b1, a7X2b1, and a6b4. All of
these integrins are speciﬁc receptors for laminins except for a3b1
that also binds to thrombospondin [65,66]. We have noticed that
the expression of the major laminin-binding integrins during the
hepatic differentiation is dynamic. The hPSCs express wide variety
of LN-speciﬁc integrins, which can explain why hPSCs can be
cultured on either Matrigel, LN-511, or LN-521. On the other hand,
compared with the SCs, the DE cells and derived cells on day 10
have less variety of laminin-speciﬁc integrins, limited to a3b1 and
a7X1b1. Nishiuchi et al. reported that a3b1, a6b4, and a7X1b1
integrins have clear binding speciﬁcity to LN-511 and LN-521 [66].
Thus, a3b1 and a7X1b1 presumably mediated the binding of the DE
and derived cells on day 10 to LN-511 and LN-521 in this study.
Upon DE induction, the cells expressed lower levels of ITGA6 and
ITGA7X2 than the hPSCs. Integrins a6b1 and a7X2b1 mediate the
binding to LN-111 [66,67]. This indicates that the DE cells have
lower capability to bind to LN-111 than the hPSCs, which can
explain our earlier observation that the hPSC-derived DE cells
poorly attached to LN-111 and to Matrigel which is mainly
composing of LN-111 [14]. We also noticed that the PHHs expressed
restricted combinations of LN-speciﬁc integrins, mainly a6b1 and
weakly a7X2b1. This expression proﬁle is distinct from that in the
SCs, DE cells, and derived cells on day 10. This is in agreement with
an earlier ﬁnding that integrin expression pattern markedly alters
during the embryonic liver development [68]. Altogether, the dy-
namic expression of integrins during hepatic differentiation and
liver development supports our claim that stage-speciﬁc matrices
in hepatic differentiation are required.
Biotransformation of endogenous and exogenous compounds is
one of the central functions of hepatocytes [69]. CYPs are vital
mono-oxygenase enzymes in transforming drugs and other
chemicals into more hydrophilic form and, thus, facilitating
excretability. Prediction of possible drug-induced hepatotoxicity is
one of the critical tasks at the preclinical stage of drugdevelopment. Human primary hepatocytes serve as the gold stan-
dard for in vitro tests [70,71] of drug biotransformation and liver
toxicity even though their limitations in terms of availability, rapid
loss of metabolizing capacity, and batch-to-batch variations are
well recognized. Together with hepatic cell lines, hPSCs offer a
promising source of hepatocytes for the in vitro models. Indeed,
only viable cells, not subcellular fractions such as microsomes, can
be used to study the whole biotransformation pathways of drugs
and chemicals. We assessed the mRNA expression of several CYPs
and their regulatory nuclear receptors by qPCR and the protein
expression of CYP3A4 by immunoﬂuorescence staining, and also
performed functional studies. During the differentiation of the
iPS(IMR90)-4 cells, we observed the upregulation ofNR3C1 and AhR
expression, a nuclear receptor responsible for DEX-mediated in-
duction of CYP3A isoforms and OMZ-mediated induction of
CYP1A1, CYP1A2, and CYP1B1 enzymes, respectively. Thus, we
tested inducibility of CYP3A4 and CYP3A7 by DEX treatment and
inducibility of CYP1A1, CYP1A2, and CYP1B1 by OMZ treatment.
OMZ signiﬁcantly induced the expression of CYP1A1 and CYP1B1
mRNA expression in the derived hepatic cells. Also CYP1A2 mRNA
expression was induced during OMZ treatment but the induction
fold could not be calculated as the enzyme was not expressed
without the OMZ exposure. We earlier noticed that CYP1A2was not
expressed in the commercial hPSC-derived hepatocyte-like cells
(unpublished observation). Also DEX induced the expression of
CYP3A7 and CYP3A4 in the hiPSC-derived cells cultured on M6. The
expression of CYP3A4 and CYP3A7 mRNA in the iPS(IMR90)-4
derived hepatic cells was signiﬁcantly increased during the differ-
entiation, and the expression of CYP3A7 mRNA reached similar
levels as in the PHHs. The activity of CYP3A enzyme was also
signiﬁcantly increased during the hepatic differentiation of the
iPS(IMR90)-4 cells, higher than that in HepaRG cells.
Taken together, the derived cells have gained hepatic functions
including synthetic functions, energy metabolism functions, and
detoxiﬁcation functions even though they still exhibited some fetal
hepatocyte phenotypes. Future work to improve maturation could
focus on the matrix composition and topology required by mature
hepatocytes. Based on our current integrin data, the ideal matrices
for hepatic maturation could be different from that for hepatic
speciﬁcation of DE cells, presumably the liver zone 3 matrix com-
ponents. Intensive study of integrins and other matrix receptors is
required for choosing right matrices. In vivo-like microenviron-
mental cues provided by biomaterials and adjacent cells in a
deﬁned conﬁguration could have beneﬁcial effects on hepatic
maturation as suggested recently [11,13].5. Conclusions
The ECM plays an important role in guiding the intrahepatic
lineage speciﬁcation and maturation during liver development and
regeneration. Thus, mimicking the stage-speciﬁc environment
in vitro is essential for bridging the gap between cell cultures and
in vivo. In this study we have discovered that liver zone 1 matrix
proteins, LN-511 and LN-521, promote the hepatic speciﬁcation of
both hESC and hiPSC-derived DE cells. The derived cells cultured on
LN-511 or LN-521 are competent to acquire certain hepatic func-
tions. The dynamic expression of integrins during hepatic differ-
entiation supports our claim that stage-speciﬁc matrices are
required to better control differentiation.Conﬂict of interest
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